Business Segments · R&D
Healthcare — R&D
STERIS Healthcare — R&D increased by 3.7% to $25.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $23.20M to $25.20M. Over 2 years (FY 2023 to FY 2025), Healthcare — R&D shows relatively stable performance with a 4.8% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ2 2022
Last reportedQ4 2025
Rolls up toR&D
How to read this metric
Higher spending signals a focus on future innovation and competitive differentiation, while lower spending may indicate a focus on short-term profitability over long-term growth.
Detailed definition
This metric tracks the investment in innovation, product development, and clinical testing specifically for the healthca...
Peer comparison
R&D intensity is a standard metric for comparing innovation pipelines among medical device manufacturers.
Metric ID:
ste_segment_healthcare_research_and_developmentHistorical Data
15 periods
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.17M | $21.17M | $21.17M | $21.17M | $22.44M | $22.44M | $22.44M | $22.44M | $22.40M | $23.70M | $23.20M | $23.69M | $22.70M | $24.30M | $25.20M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.0% | +0.0% | +0.0% | +0.0% | -0.2% | +5.8% | -2.1% | +2.1% | -4.2% | +7.0% | +3.7% |
| YoY Change | — | — | — | — | +6.0% | +6.0% | +6.0% | +6.0% | -0.2% | +5.6% | +3.4% | +5.6% | +1.3% | +2.5% | +8.6% |
Range$21.17M – $25.20M
CAGR+5.1%
Avg YoY Growth+4.6%
Median YoY Growth+5.6%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's healthcare — r&d?
- STERIS (STE) reported healthcare — r&d of $25.20M in Q4 2025.
- How has STERIS's healthcare — r&d changed year-over-year?
- STERIS's healthcare — r&d increased by 8.6% year-over-year, from $23.20M to $25.20M.
- What is the long-term trend for STERIS's healthcare — r&d?
- Over 2 years (2023 to 2025), STERIS's healthcare — r&d has grown at a 4.8% compound annual growth rate (CAGR), from $84.68M to $92.99M.
- What does healthcare — r&d mean?
- Expenditures dedicated to developing new products and improving existing technologies within the healthcare segment.